About
Inspiro Medical is a medical device company dedicated to the development of an inhalation platform designed to deliver small molecules, such as corticosteroids or beta agonists, and macromolecules such as antibodies or vaccines. Inspiro Medical is developing Inspiromatic, a dry powder inhaler (DPI) that uses technology to overcome the drawbacks of current inhalers and ensure optimal drug delivery. The company's proprietary DPI combines an active dry powder fluidization mechanism that works at low-inhalation flow rates with a real-time feedback control and data logger indicating proper inhalation technique and follow-up. Young children and the elderly can particularly benefit from the advantages of Inspiro's dry powder inhalation solution.